The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2018 / Jan / A New Era for Cell Culture Media
Discovery & Development Bioprocessing Biopharma Formulation Sponsored

A New Era for Cell Culture Media

How a better understanding of raw materials has increased the potential for biopharmaceutical companies to understand their process variability.How a better understanding of raw materials has increased the potential for biopharmaceutical companies to understand their process variability.

01/17/2018 1 min read

Share

A better understanding of raw materials has increased the potential for biopharma companies to understand their process variability – and to control it.

Download the eBook here

A better understanding of raw materials has increased the potential for biopharma companies to understand their process variability – and to control it.

Download the eBook here

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Choosing a Sterile Fill-Finish Partner
Outsourcing
Choosing a Sterile Fill-Finish Partner

October 22, 2026

5 min read

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

Can Clinical Trials Collect Less Data Without Compromising Safety?
Industry News Development & Clinical Regulation & Standards
Can Clinical Trials Collect Less Data Without Compromising Safety?

October 22, 2026

5 min read

Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.

Meeting the Demands of Injectable Drug Delivery
Drug Delivery
Meeting the Demands of Injectable Drug Delivery

October 22, 2026

1 min read

Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations

Analytical Champions: Robert Wethman
Bioprocessing Biopharma Interviews
Analytical Champions: Robert Wethman

October 21, 2026

6 min read

Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: